Colorado Springs, CONCT07496567Now EnrollingIRB Ready

Macular Degeneration Clinical Trial in Colorado Springs, CO

Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Colorado Springs. Study-provided care at no cost to qualified participants.

Sponsored by EyeBiotech Ltd.

Quick Self-Assessment

See if you qualify for this Colorado Springs location

Preparing your pre-screening questions…

Expert Care in Colorado Springs

Access macular degeneration specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related macular degeneration treatment provided free

Apply for This Colorado Springs Location

Check if you qualify for this macular degeneration clinical trial in Colorado Springs, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Colorado Springs

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Colorado Springs site if eligible
  4. 4Begin participation

About This Macular Degeneration Study in Colorado Springs

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD. The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.

Sponsor: EyeBiotech Ltd.

Who Can Participate

Inclusion Criteria

include but are not limited to the following:
Has treatment naive choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) including subfoveal, juxtafoveal and extrafoveal lesions or retinal angiomatous proliferations (RAP) and polypoidal choroidal vascularization (PCV) lesions in at least one eye (study eye)
The diagnosis of neovascular age-related macular degeneration (NVAMD) must have been made within 21 days prior to starting study treatment The main

Exclusion Criteria

include but are not limited to the following
Has uncontrolled blood pressure at screening
History of any prior macular laser photocoagulation in the study eye
History of uveitis in either eye
History of cataract surgery, minimally invasive glaucoma surgery, or Yttrium-Aluminium Garnet (Yag) laser capsulotomy in the study eye within 90 days before entering the study
Has uncontrolled glaucoma in the study eye
Active retinal disease other than the condition under investigation in the study eye
Has previously received anti- vascular endothelial growth factor (VEGF) therapy or other intravitreal (IVT) therapy in the study eye

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Colorado Springs?

Yes, this clinical trial (NCT07496567) has an active research site in Colorado Springs, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Macular Degeneration Treatment Options in Colorado Springs, CO

If you're searching for macular degeneration treatment options in Colorado Springs, CO, this clinical trial (NCT07496567) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Colorado Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all macular degeneration clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Colorado Springs, CO

See all rheumatoid arthritis clinical trials recruiting in Colorado Springs — not just this study.

Browse Rheumatoid Arthritis Trials in Colorado Springs →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsMacular Degeneration TrialsWet Age-Related Macular Degeneration TrialsAll Conditions →

Ready to Join in Colorado Springs?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Colorado Springs, CO